Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Recognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivors.

Trachtenberg E, Gurion R, Mashiach T, Tadmor T, Kedmi M, Dann EJ.

Leuk Lymphoma. 2019 Jul 22:1-6. doi: 10.1080/10428194.2019.1641803. [Epub ahead of print]

PMID:
31331223
2.

Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents-a multicenter historical prospective study.

Ram R, Amit O, Zuckerman T, Gurion R, Raanani P, Bar-On Y, Avivi I, Wolach O.

Ann Hematol. 2019 Aug;98(8):1927-1932. doi: 10.1007/s00277-019-03719-6. Epub 2019 Jun 11.

PMID:
31187237
3.

Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma.

Abadi U, Peled L, Gurion R, Rotman-Pikielny P, Raanani P, Ellis MH, Rozovski U.

Leuk Lymphoma. 2019 Jun 6:1-5. doi: 10.1080/10428194.2019.1620946. [Epub ahead of print]

PMID:
31167584
4.

Bendamustine for patients with indolent B cell lymphoproliferative malignancies including chronic lymphocytic leukaemia - an updated meta-analysis.

Vidal L, Gurion R, Shargian L, Dreyling M, Gafter-Gvili A.

Br J Haematol. 2019 Jul;186(2):234-242. doi: 10.1111/bjh.15901. Epub 2019 Apr 13.

PMID:
30980398
5.

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

Younes A, Sehn LH, Johnson P, Zinzani PL, Hong X, Zhu J, Patti C, Belada D, Samoilova O, Suh C, Leppä S, Rai S, Turgut M, Jurczak W, Cheung MC, Gurion R, Yeh SP, Lopez-Hernandez A, Dührsen U, Thieblemont C, Chiattone CS, Balasubramanian S, Carey J, Liu G, Shreeve SM, Sun S, Zhuang SH, Vermeulen J, Staudt LM, Wilson W; PHOENIX investigators.

J Clin Oncol. 2019 May 20;37(15):1285-1295. doi: 10.1200/JCO.18.02403. Epub 2019 Mar 22.

6.

FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma.

Vaxman I, Bernstine H, Kleinstern G, Hendin N, Shimony S, Domachevsky L, Gurion R, Groshar D, Raanani P, Gafter-Gvili A.

Hematol Oncol. 2019 Apr;37(2):168-175. doi: 10.1002/hon.2578. Epub 2019 Mar 18.

PMID:
30734341
7.

The role of maintenance therapy in patients with diffuse large B cell lymphoma: A systematic review and meta-analysis.

Rozental A, Gafter-Gvili A, Vidal L, Raanani P, Gurion R.

Hematol Oncol. 2019 Feb;37(1):27-34. doi: 10.1002/hon.2561. Epub 2018 Oct 8.

PMID:
30216478
8.

Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma.

Gurion R, Bernstine H, Domachevsky L, Michelson C, Raanani P, Vidal L, Shochat T, Gafter-Gvili A.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):687-691. doi: 10.1016/j.clml.2018.06.022. Epub 2018 Jun 27.

PMID:
30017596
9.

Hypomethylating Agents-associated Infections-Systematic Review and Meta-analysis of Randomized Controlled Trials.

Shargian-Alon L, Gurion R, Raanani P, Yahav D, Gafter-Gvili A.

Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):603-610.e1. doi: 10.1016/j.clml.2018.05.017. Epub 2018 May 28.

PMID:
29921527
10.

PET-adapted therapy for advanced Hodgkin lymphoma - systematic review.

Amitai I, Gurion R, Vidal L, Dann EJ, Raanani P, Gafter-Gvili A.

Acta Oncol. 2018 Jun;57(6):765-772. doi: 10.1080/0284186X.2018.1426877. Epub 2018 Jan 18. Review.

PMID:
29345517
11.

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.

Yeshurun M, Vaxman I, Shargian L, Yahav D, Bishara J, Pasvolsky O, Wolach O, Lahav M, Gurion R, Magen H, Vidal L, Herscovici C, Peck A, Moshe M, Sela-Navon M, Naparstek E, Raanani P, Rozovski U.

Clin Microbiol Infect. 2018 Jul;24(7):749-754. doi: 10.1016/j.cmi.2017.11.019. Epub 2017 Dec 6.

12.

Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?

Bentur OS, Gurion R, Gafter-Gvili A, Gatt M, Shvidel L, Horowitz NA, Ram R, Herishanu Y, Sarid N, Paltiel O, Ganzel C, Kreiniz N, Dally N, Gutwein O, Raanani P, Avivi I, Perry C.

Leuk Lymphoma. 2018 May;59(5):1163-1171. doi: 10.1080/10428194.2017.1375102. Epub 2017 Sep 13.

PMID:
28901817
13.

The effect of R-CHOP dose reduction on overall survival of elderly patients with DLBCL - comparative study.

Vidal L, Lando S, Vaxman I, Shochat T, Raanani P, Gurion R, Gafter-Gvili A.

Leuk Lymphoma. 2018 Apr;59(4):904-910. doi: 10.1080/10428194.2017.1365856. Epub 2017 Aug 22.

PMID:
28828883
14.

Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.

Gafter-Gvili A, Gurion R, Raanani P, Shpilberg O, Vidal L.

Hematol Oncol. 2017 Dec;35(4):424-431. doi: 10.1002/hon.2350. Epub 2016 Oct 13. Review.

PMID:
27734524
15.

First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response - systematic review and meta-analysis.

Gurion R, Raanani P, Vidal L, Leader A, Gafter-Gvili A.

Acta Oncol. 2016 Sep - Oct;55(9-10):1077-1083. doi: 10.1080/0284186X.2016.1201214. Epub 2016 Aug 25. Review.

PMID:
27560448
16.

Central nervous system involvement in T-cell lymphoma: A single center experience.

Gurion R, Mehta N, Migliacci JC, Zelenetz A, Moskowitz A, Lunning M, Moskowitz C, Hamlin P, Horwitz S.

Acta Oncol. 2016 May;55(5):561-6. doi: 10.3109/0284186X.2015.1118656. Epub 2016 Apr 4.

17.

Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.

Vidal L, Gurion R, Ram R, Raanani P, Bairey O, Robak T, Gafter-Gvili A, Shpilberg O.

Leuk Lymphoma. 2016 Sep;57(9):2047-57. doi: 10.3109/10428194.2016.1154956. Epub 2016 Mar 16. Review.

PMID:
26980554
18.

Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single-centre experience.

Atzmony L, Amitay-Laish I, Gurion R, Shahal-Zimra Y, Hodak E.

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2382-9. doi: 10.1111/jdv.13243. Epub 2015 Aug 24.

PMID:
26299651
19.

Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.

Bairey O, Shacham-Abulafia A, Shpilberg O, Gurion R.

Hematol Oncol. 2016 Dec;34(4):184-192. doi: 10.1002/hon.2233. Epub 2015 Jun 5.

PMID:
26052918
20.

CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma--a meta-analysis of randomized controlled trials.

Vidal L, Shpilberg O, Gurion R, Monsef I, Raanani P, Ram R, Gafter-Gvili A.

Acta Oncol. 2016;55(1):77-84. doi: 10.3109/0284186X.2015.1043025. Epub 2015 May 21. Review.

PMID:
25997705
21.

Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study.

Gafter-Gvili A, Ribakovsky E, Mizrahi N, Avigdor A, Aviv A, Vidal L, Ram R, Perry C, Avivi I, Kedmi M, Nagler A, Raanani P, Gurion R.

Leuk Lymphoma. 2016;57(1):63-9. doi: 10.3109/10428194.2015.1046862. Epub 2015 May 25.

PMID:
25944378
22.

Primary cutaneous γ/δ T-cell lymphoma. An atypical case with bone marrow granulomas.

Shalom G, Gurion R, Benharroch D.

J Dermatol Case Rep. 2015 Mar 31;9(1):15-8. doi: 10.3315/jdcr.2015.1191. eCollection 2015 Mar 31.

23.

Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature.

Gurion R, Tangpricha V, Yow E, Schanberg LE, McComsey GA, Robinson AB; Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators.

Pediatr Rheumatol Online J. 2015 Apr 23;13:13. doi: 10.1186/s12969-015-0008-x. Review.

24.

Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy.

Robinson AB, Tangpricha V, Yow E, Gurion R, Schanberg LE, McComsey GA; APPLE Investigators.

Lupus Sci Med. 2014 Sep 10;1(1):e000037. doi: 10.1136/lupus-2014-000037. eCollection 2014.

25.

Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy.

Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg LE; APPLE Investigators.

Lupus Sci Med. 2014 Apr 30;1(1):e000011. doi: 10.1136/lupus-2014-000011. eCollection 2014.

26.

Fever and rash in children: important diagnostic considerations.

Gurion R, Sabella C, Zeft AS.

Minerva Pediatr. 2013 Dec;65(6):575-85.

PMID:
24217627
27.

Systematic review and meta-analysis of autologous stem cell transplantation in peripheral T cell lymphoma.

Gurion R.

Acta Haematol. 2014;131(2):112-3. doi: 10.1159/000354818. Epub 2013 Oct 19. No abstract available.

PMID:
24157952
28.

Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.

Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.

Transplantation. 2013 Oct 15;96(7):657-63. doi: 10.1097/TP.0b013e31829b0718.

PMID:
23823652
29.

Tocilizumab in pediatric rheumatology: the clinical experience.

Gurion R, Singer NG.

Curr Rheumatol Rep. 2013 Jul;15(7):338. doi: 10.1007/s11926-013-0338-y. Review.

PMID:
23715975
30.

A 4-year-old Amish boy with weakness, arthritis, rash, verbal delay, and failure to thrive.

Gurion R, Nwankwo C, Nanda K, Brooks EB, Mitchell AL, Wiznitzer M, Robinson AB.

Arthritis Care Res (Hoboken). 2013 Sep;65(9):1539-47. doi: 10.1002/acr.22019. Review. No abstract available.

31.

Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.

Gurion R, Siu A, Weiss AR, Masterson M.

J Pediatr Pharmacol Ther. 2012 Jul;17(3):274-80. doi: 10.5863/1551-6776-17.3.274.

32.

Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.

Vidal L, Gafter-Gvili A, Gurion R, Raanani P, Dreyling M, Shpilberg O.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009045. doi: 10.1002/14651858.CD009045.pub2. Review.

PMID:
22972131
33.

Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis.

Gurion R, Gafter-Gvili A, Vidal L, Leader A, Ram R, Shacham-Abulafia A, Paul M, Ben-Bassat I, Shpilberg O, Raanani P.

Haematologica. 2013 Jan;98(1):95-102. doi: 10.3324/haematol.2012.063172. Epub 2012 Aug 8. Review.

34.

Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.

Gurion R, Belnik-Plitman Y, Gafter-Gvili A, Paul M, Vidal L, Ben-Bassat I, Shpilberg O, Raanani P.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD008238. doi: 10.1002/14651858.CD008238.pub3. Review.

PMID:
22696376
35.

Systemic arthritis in children: a review of clinical presentation and treatment.

Gurion R, Lehman TJ, Moorthy LN.

Int J Inflam. 2012;2012:271569. doi: 10.1155/2012/271569. Epub 2011 Dec 25.

36.

Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.

Gurion R, Belnik-Plitman Y, Gafter-Gvili A, Paul M, Vidal L, Ben-Bassat I, Shpilberg O, Raanani P.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008238. doi: 10.1002/14651858.CD008238.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD008238.

PMID:
21901718
37.

High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis.

Gafter-Gvili A, Leader A, Gurion R, Vidal L, Ram R, Shacham-Abulafia A, Ben-Bassat I, Lishner M, Shpilberg O, Raanani P.

Am J Hematol. 2011 Aug;86(8):657-62. doi: 10.1002/ajh.22076. Review.

38.

The use of myeloid colony-stimulating factors in hematologic malignancies: the role of systematic reviews and meta-analyses.

Gurion R, Shacham-Abulafia A, Shpilberg O, Raanani P.

Acta Haematol. 2011;125(1-2):68-79. doi: 10.1159/000318898. Epub 2010 Dec 8. Review.

PMID:
21150189
39.

5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome--a systematic review and meta-analysis.

Gurion R, Vidal L, Gafter-Gvili A, Belnik Y, Yeshurun M, Raanani P, Shpilberg O.

Haematologica. 2010 Feb;95(2):303-10. doi: 10.3324/haematol.2009.010611. Epub 2009 Sep 22.

40.

Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis.

Gurion R, Gafter-Gvili A, Paul M, Vidal L, Ben-Bassat I, Yeshurun M, Shpilberg O, Raanani P.

Haematologica. 2009 May;94(5):712-9. doi: 10.3324/haematol.2008.002170. Epub 2009 Mar 31. Review.

41.

ATG plus cyclosporine reduces all-cause mortality in patients with severe aplastic anemia--systematic review and meta-analysis.

Gafter-Gvili A, Ram R, Gurion R, Paul M, Yeshurun M, Raanani P, Shpilberg O.

Acta Haematol. 2008;120(4):237-43. doi: 10.1159/000203403. Epub 2009 Feb 25. Review.

PMID:
19246887
42.

18F-fluorodeoxyglucose-Avid mammary mass in a patient with insulin-dependent diabetes mellitus and Hodgkin's lymphoma: relapse or pitfall?

Gurion R, Groshar D, Schindel A, Shpilberg O, Raanani P.

Isr Med Assoc J. 2006 Dec;8(12):838-9. No abstract available.

43.

[A new method for the rapid diagnosis of plague in dead rodents].

Markenson Y, Ben Gurion R, Ben Efraim S.

Ann Inst Pasteur (Paris). 1971 Aug;121(2):183-5. French. No abstract available.

PMID:
5165365

Supplemental Content

Loading ...
Support Center